Implanon contraceptive implant: information for women and healthcare professionals
- Medicines and Healthcare products Regulatory Agency
- 12 January 2011
- Therapeutic area:
- Obstetrics, gynaecology and fertility
Article date: January 2011
In light of recent media coverage regarding the contraceptive implant Implanon, we have highlighted our previous advice to support safer use of this product. This follows reports of problems with the insertion and removal of Implanon. Click here to view the information; further information about Implanon and the transition to a new version (called Nexplanon) is available from the October 2010 issue of Drug Safety Update.
BNF section 184.108.40.206 Parenteral progestogen-only contraceptives
Article citation: Drug Safety Update Jan 2011, vol 4 issue 6: S3.
Published: 12 January 2011
Therapeutic area: Obstetrics, gynaecology and fertility